News
Biden administration proposal threatens innovative research
Biden administration proposal threatens innovative research at universities across the country
UCLA students transition between classes at the Westwood campus on September 27, 2022. (Photo by Dean Musgrove, Los Angeles Daily News/SCNG)
CrewLAB Raises $1.6M to Democratize Data & Technology for Endurance Sports Teams
CrewLAB Raises $1.6M to Democratize Data & Technology for Endurance Sports Teams
GV Backs Hair Loss Biotech out of UCLA with PhII set for mid-2024
Pelage Pharmaceuticals, a Los Angeles-based hair loss biotech based on research out of UCLA, has reeled in a $16.75 million Series A and plans to start a mid-stage trial later this year.
See full article below;
Immpact Bio Awarded $8million CIRM Grant
Please see full article on PR News below:
LABEST 2024 Early Bird On Sale Now
Early Bird Tickets to LABEST 2024 are now available.
The Lancet Neurology features UCLA researcher Rhonda Voskuhl
UCLA Researcher Rhonda Voskuhl featured in neurology journal
UCLA TDG Innovation Magazine Winter 2023
UCLA TDG Innovation Magazine Winter 2023 Highlights
* UCLA TDG by the Numbers
* UCLA Ranks #1 in Scientific Publications in the LA Region
* Equatic named one of TIME Magazine's Best Inventions of 2023
* FDA Fast Track for ImmPact Bio therapeutic
* Autobahn and UCLA
and more
Autobahn Labs Announces Key Licensing Milestones in Alliances with Early University Partners
PALO ALTO, CA, USA, November 14, 2023 – Autobahn Labs, an early-stage drug discovery incubator, announced today that it had executed exclusive license agreements to foundational technologies in its collaborations with the Los Angeles and San Francisco campuses of the University of California. The objective of Autobahn’s collaborations with its academic partners is to identify academic research programs targeting important unmet medical needs and to advance their commercialization in companies it launches.